Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
600267 Zhejiang Hisun Pharmaceutical
- 8.76
- +0.08+0.92%
Not Open Dec 12 15:00 CST
10.58BMarket Cap-515.29P/E (TTM)
8.77High8.60Low136.35KlotVolume8.66Open8.68Pre Close118.91MTurnover1.14%Turnover RatioLossP/E (Static)1.21BShares9.8452wk High1.28P/B10.50BFloat Cap6.4352wk Low9.55Limit Up1.20BShs Float27.24Historical High7.81Limit Down1.96%Amplitude1.42Historical Low--Dividend TTM8.72Avg Price62.98KlotAsk--Div YieldTTM100Lot Size71.67KlotBid
Zhejiang Hisun Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -5.21%1.48B | 7.49%1.44B | -0.74%1.57B | 13.43%1.59B | 23.78%1.57B | 2.48%1.34B | 1.50%1.58B | 7.95%1.4B | -18.00%1.26B | 17.97%1.31B |
| Transactional financial assets | ---- | ---- | ---- | --292.62K | ---- | ---- | ---- | ---- | -59.56%684K | 75.95%1.75M |
| Notes receivable and accounts receivable | -24.26%1.94B | -23.51%2.04B | -20.82%1.96B | -21.92%1.92B | 9.21%2.56B | 23.37%2.67B | 13.12%2.48B | 17.31%2.46B | 8.40%2.35B | 3.79%2.17B |
| -Notes receivable | ---- | ---- | ---- | ---- | --46.79M | -22.21%8.3M | 1,362.78%4.39M | ---- | ---- | 240.15%10.67M |
| -Accounts receivable | -22.85%1.94B | -23.27%2.04B | -20.68%1.96B | -21.92%1.92B | 7.22%2.52B | 23.59%2.66B | 12.94%2.47B | 17.31%2.46B | 8.40%2.35B | 3.44%2.16B |
| Other receivables (including interest and dividends) | 31.89%280.92M | -4.81%221.03M | -24.88%203.48M | -18.46%203.51M | -59.57%212.99M | -41.03%232.2M | -30.45%270.88M | -39.72%249.57M | 64.20%526.77M | 26.07%393.74M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | --1.18M | ---- | ---- | ---- | ---- |
| -Other receivable | ---- | -4.32%221.03M | ---- | ---- | ---- | -41.33%231.02M | ---- | -39.72%249.57M | ---- | 26.07%393.74M |
| Advance payment | -20.38%156.94M | -6.74%204.58M | -0.97%242.42M | -16.01%214.09M | -18.47%197.11M | -14.62%219.36M | -7.68%244.78M | 12.87%254.9M | 8.51%241.77M | 50.38%256.94M |
| Inventories | -7.84%1.73B | -0.93%1.75B | -3.66%1.83B | 2.23%1.96B | 14.67%1.88B | 7.90%1.77B | 5.06%1.9B | -5.38%1.91B | -23.73%1.64B | -30.23%1.64B |
| Receivable financing | -18.37%132.24M | 19.40%227.19M | 9.42%256.31M | 53.07%148.96M | 103.27%162M | 24.31%190.28M | 34.58%234.25M | -33.37%97.32M | -57.12%79.7M | -32.41%153.06M |
| Other current assets | 67.77%59.07M | 486.70%214.18M | 741.37%313.25M | 745.07%331.38M | 8.76%35.21M | -65.35%36.51M | -75.15%37.23M | -76.01%39.21M | -81.37%32.37M | -49.83%105.36M |
| Total current assets | -12.53%5.78B | -5.50%6.11B | -5.46%6.37B | -0.78%6.36B | 7.88%6.61B | 7.23%6.46B | 3.16%6.74B | 0.71%6.41B | -9.30%6.13B | -6.84%6.03B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -0.54%20.03M | 0.00%20.09M | -0.18%20.18M | -0.07%20.2M | -0.32%20.14M | -0.58%20.09M | 0.07%20.22M | 0.07%20.22M | -49.71%20.2M | -49.71%20.2M |
| Investment real estate | -7.65%95.21M | -7.56%96.79M | -7.45%98.37M | -7.03%99.24M | -2.87%103.09M | -2.86%104.71M | 27.12%106.29M | 25.80%106.75M | 26.70%106.14M | 48.09%107.79M |
| Long-term equity investment | 9.96%1.46B | -0.09%1.43B | -0.73%1.44B | -4.61%1.39B | -4.99%1.32B | 0.21%1.43B | 5.35%1.45B | 8.41%1.46B | 5.10%1.39B | 6.22%1.43B |
| Fixed assets | ---- | 0.03%7.43B | ---- | ---- | ---- | -5.79%7.43B | ---- | -4.30%7.81B | ---- | 1.61%7.89B |
| Constru in process | ---- | -68.35%387.21M | ---- | ---- | ---- | -19.44%1.22B | ---- | -19.26%1.24B | ---- | -34.44%1.52B |
| Intangible assets | -19.70%962.68M | -15.77%1.04B | -21.40%1.02B | -19.72%1.07B | -12.16%1.2B | -13.14%1.23B | -10.51%1.3B | -5.80%1.34B | 12.98%1.36B | 34.81%1.42B |
| Development expenditure | -75.08%46.21M | -9.20%168.18M | -9.07%167.7M | -8.72%167.7M | 1.65%185.41M | 4.04%185.23M | 5.24%184.43M | 5.63%183.72M | 6.00%182.39M | -41.64%178.04M |
| Long deferred expense | -61.53%6.12M | -40.43%6.86M | -38.02%7.66M | -20.23%8.56M | 59.36%15.9M | 19.80%11.51M | 5.64%12.36M | -18.90%10.73M | 0.74%9.98M | -16.21%9.61M |
| Deferred tax assets | 31.79%152.8M | 53.48%174.48M | 94.97%183.03M | 86.78%179.62M | 15.38%115.94M | 8.44%113.68M | -19.11%93.88M | -18.90%96.17M | -39.88%100.49M | -45.01%104.83M |
| Usufruct assets | 58.48%66.37M | -11.58%39.66M | -12.68%40.97M | -8.11%38.91M | -2.48%41.88M | -1.62%44.85M | 0.82%46.92M | -10.42%42.34M | 152.23%42.95M | 141.44%45.59M |
| Other non current assets | -54.34%25.15M | -61.50%21.03M | 15.95%59.54M | 14.94%59.78M | 7.47%55.09M | -14.54%54.63M | -19.34%51.35M | -15.89%52.01M | -72.61%51.26M | -68.33%63.93M |
| Total non current assets | -9.08%10.47B | -8.75%10.82B | -8.59%11.06B | -9.01%11.25B | -7.17%11.52B | -7.28%11.85B | -6.46%12.1B | -4.93%12.37B | -6.01%12.41B | -4.70%12.78B |
| Total assets | -10.34%16.26B | -7.60%16.93B | -7.47%17.43B | -6.20%17.61B | -2.19%18.13B | -2.63%18.32B | -3.23%18.84B | -3.08%18.78B | -7.12%18.54B | -5.40%18.81B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -5.00%2.48B | -2.97%2.65B | -1.86%2.64B | -10.10%2.16B | -4.52%2.61B | -26.89%2.73B | -36.41%2.69B | -39.84%2.4B | -33.85%2.73B | -17.85%3.74B |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | -99.82%69.77K | -54.71%1.25M | ---- | 43.20%1.55M | 5,236.10%37.89M | 64.83%2.77M |
| Notes payable and accounts payable | -16.59%1B | 0.79%1.18B | 7.54%1.38B | -14.12%1.31B | -3.62%1.2B | -5.11%1.17B | -2.44%1.28B | 15.87%1.53B | -11.58%1.25B | -12.81%1.24B |
| -Notes payable | -24.14%294.48M | 10.54%429.64M | -1.77%518.2M | -10.71%445.77M | 17.19%388.19M | 0.38%388.67M | 38.40%527.51M | 59.93%499.22M | 4.11%331.24M | 3.61%387.21M |
| -Accounts payable | -12.99%709.18M | -4.04%753.28M | 14.02%863M | -15.77%868.42M | -11.13%815.09M | -7.62%785M | -19.08%756.88M | 2.24%1.03B | -16.14%917.2M | -18.68%849.71M |
| Contract liabilities | 36.95%116.28M | 5.35%104.52M | -31.93%109.48M | -10.58%106.46M | -47.69%84.9M | -60.34%99.21M | -44.78%160.83M | -55.65%119.05M | -46.72%162.31M | -14.29%250.13M |
| Advance receipts | --40K | --40K | --40K | --40K | ---- | ---- | ---- | ---- | ---- | ---- |
| Salaries payable | 28.79%393.53M | 11.73%330.59M | 6.67%258.68M | -11.56%353.8M | -13.22%305.57M | -3.42%295.87M | 6.12%242.51M | -2.32%400.07M | 4.05%352.14M | 9.28%306.36M |
| Taxs payable | -10.16%142.89M | -17.83%121.68M | -34.56%96.87M | -36.54%140.94M | -15.50%159.05M | 46.88%148.09M | 10.88%148.02M | 7.47%222.09M | -15.33%188.23M | -43.02%100.82M |
| Other payable (including interest and dividends) | -13.40%1.22B | 6.27%1.46B | -0.91%1.32B | 12.95%1.37B | 17.86%1.41B | 13.77%1.38B | 14.84%1.33B | -2.13%1.21B | -1.40%1.2B | 29.09%1.21B |
| -Other payable | ---- | 6.27%1.46B | ---- | ---- | ---- | 13.77%1.38B | ---- | -2.13%1.21B | ---- | 29.09%1.21B |
| Non current liabilities due within one year | 9.63%883.11M | -5.95%847.64M | 27.99%1.09B | 77.85%1.14B | 18.78%805.56M | 17.58%901.24M | 19.57%850.46M | -24.19%639.54M | 43.18%678.18M | 48.46%766.51M |
| Other current liabilities | 40.40%6.89M | 4,635.21%308.72M | -3.19%308.47M | -98.92%6.61M | -99.20%4.9M | -97.88%6.52M | -38.53%318.63M | 19.83%610.78M | 17.74%611.82M | -40.14%307.69M |
| Total current liabilities | -5.11%6.25B | 4.09%7.01B | 2.51%7.21B | -7.70%6.58B | -8.67%6.58B | -14.94%6.74B | -18.21%7.03B | -18.80%7.13B | -16.33%7.21B | -8.84%7.92B |
| Current liabilities | ||||||||||
| Long term loan | 3.75%1.27B | 7.59%1.32B | -12.00%1.28B | -28.08%1.12B | -10.66%1.22B | -14.26%1.22B | 0.51%1.45B | 17.63%1.55B | -19.34%1.37B | -15.92%1.43B |
| Bonds payable | ---- | ---- | -77.77%337.72M | -16.79%1.25B | -16.79%1.24B | -16.77%1.22B | 4.59%1.52B | 4.59%1.5B | 4.59%1.49B | 4.59%1.47B |
| Estimate liabilities | ---- | ---- | --74.08M | --74.08M | ---- | ---- | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -7.38%24.25M | -5.07%24.13M | 58.93%28.55M | 25.96%22.63M | 53.39%26.18M | 41.93%25.42M | -18.09%17.97M | -13.32%17.97M | -25.40%17.07M | -33.08%17.91M |
| Long term deferred income | -12.39%164.77M | -11.44%174.48M | -10.61%178.84M | -10.23%185.96M | -11.52%188.06M | -11.89%197.01M | -1.61%200.06M | -4.22%207.15M | -6.61%212.56M | -6.15%223.59M |
| Lease liabilities | 59.42%54.41M | -2.30%34.82M | -7.82%34.04M | -9.98%29.15M | -8.36%34.13M | -8.37%35.64M | -5.80%36.92M | -13.79%32.38M | 303.93%37.24M | 235.31%38.9M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -56.57%211.12M | -68.07%211.12M |
| Total non current liabilities | -44.13%1.51B | -42.68%1.55B | -40.15%1.93B | -19.14%2.68B | -18.75%2.71B | -20.17%2.71B | -4.35%3.23B | 2.18%3.31B | -13.74%3.34B | -16.14%3.39B |
| Total liabilities | -16.49%7.76B | -9.31%8.56B | -10.91%9.14B | -11.33%9.26B | -11.86%9.29B | -16.51%9.44B | -14.30%10.26B | -13.14%10.45B | -15.53%10.54B | -11.15%11.31B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.21B | -0.14%1.21B | 2.33%1.21B | 0.81%1.21B | 0.81%1.21B | 0.95%1.21B | -1.52%1.18B | 0.18%1.2B | 0.17%1.2B | 2.51%1.2B |
| Other equity instruments | ---- | ---- | -78.75%91.03M | -20.41%340.9M | -20.41%340.9M | -20.41%340.9M | 0.00%428.33M | 0.00%428.33M | 0.00%428.33M | 0.00%428.33M |
| Capital reserve funds | 1.90%4.36B | -0.27%4.36B | 9.09%4.35B | 4.40%4.35B | 8.05%4.28B | 22.86%4.37B | 12.48%3.99B | 18.58%4.16B | 14.76%3.96B | 10.10%3.55B |
| Surplus reserve funds | 7.35%554.12M | 7.35%554.12M | 7.35%554.12M | 7.34%554.12M | 11.06%516.2M | 11.06%516.2M | 11.06%516.2M | 11.06%516.21M | 15.72%464.81M | 15.72%464.81M |
| Retained profit | -2.28%2.5B | -3.97%2.42B | -12.34%2.23B | -14.28%1.98B | 15.86%2.56B | 14.76%2.52B | 16.94%2.54B | 13.60%2.31B | 4.99%2.21B | 17.67%2.19B |
| Less:Treasury stock | 10.92%375.6M | 22.17%429.31M | 14.80%400.03M | -37.92%341.15M | -35.95%338.62M | -7.71%351.4M | -3.48%348.47M | 62.72%549.56M | 121.09%528.71M | --380.75M |
| Other composite income | -9.89%11.66M | -20.94%11.09M | 20.94%11.45M | 12.08%12.17M | -0.14%12.94M | 111.06%14.03M | 2,111.79%9.47M | 92.11%10.86M | -28.85%12.96M | -84.14%6.65M |
| Shareholders equity without minority interests | -3.71%8.25B | -5.77%8.12B | -3.28%8.04B | 0.28%8.1B | 10.76%8.57B | 15.38%8.61B | 11.62%8.32B | 10.62%8.08B | 5.22%7.74B | 4.65%7.47B |
| Minority interests | -9.27%242.51M | -6.37%246.31M | -5.82%245.3M | -1.46%247.44M | 4.61%267.28M | 570.52%263.06M | 504.15%260.46M | 494.63%251.1M | 107.59%255.5M | 57.29%39.23M |
| Total shareholder equity | -3.88%8.5B | -5.79%8.36B | -3.36%8.29B | 0.23%8.35B | 10.56%8.84B | 18.28%8.88B | 14.45%8.58B | 13.41%8.33B | 6.91%7.99B | 4.84%7.5B |
| Total liabilityies and equity | -10.34%16.26B | -7.60%16.93B | -7.47%17.43B | -6.20%17.61B | -2.19%18.13B | -2.63%18.32B | -3.23%18.84B | -3.08%18.78B | -7.12%18.54B | -5.40%18.81B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
